Stock Analysis on Net
Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

This company has been moved to the archive! The financial data has not been updated since February 15, 2024.

Common-Size Income Statement

Vertex Pharmaceuticals Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Product revenues, net 100.00 100.00 99.99 99.95 99.95
Other revenues 0.00 0.00 0.01 0.05 0.05
Revenues 100.00% 100.00% 100.00% 100.00% 100.00%
Cost of sales -12.79 -12.10 -11.94 -11.86 -13.16
Gross profit 87.21% 87.90% 88.06% 88.14% 86.84%
Research and development expenses -32.05 -28.44 -25.58 -26.51 -42.15
Acquired in-process research and development expenses -5.34 -1.29 -14.70 -2.97 0.00
Sales, general and administrative expenses -11.52 -10.58 -11.09 -12.42 -15.82
Change in fair value of contingent consideration 0.52 0.64 0.04 -0.21 -0.11
Income from operations 38.83% 48.23% 36.73% 46.03% 28.77%
Interest income 6.23 1.62 0.06 0.36 1.53
Interest expense -0.45 -0.61 -0.81 -0.94 -1.41
Other income (expense), net -0.23 -1.85 0.06 4.78 4.62
Income before provision for income taxes 44.38% 47.39% 36.05% 50.22% 33.51%
Provision for income taxes -7.70 -10.19 -5.13 -6.53 -5.24
Net income 36.68% 37.20% 30.92% 43.70% 28.27%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Income from operations The net result for the period of deducting operating expenses from operating revenues. Vertex Pharmaceuticals Inc. income from operations as a percentage of revenues increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.
Income before provision for income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Vertex Pharmaceuticals Inc. income before provision for income taxes as a percentage of revenues increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Vertex Pharmaceuticals Inc. net income as a percentage of revenues increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.